Lucid Diligence Brief: General Proximity and Daiichi Sankyo multi-target induced-proximity oncology deal
Lucid Diligence Brief: General Proximity and Daiichi Sankyo multi-target…
Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design collaboration
Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design…
ELCC 2025 Preview: Key Lung Cancer Highlights to Watch
ELCC 2025 at a glance Looking toward ELCC 2025, LucidQuest highlights…


